# Meng Yuan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/meng-yuan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,325 |
| Field | Lung Cancer Diagnosis and Treatment |
| h-index | 19 |
| i10-index | 38 |
| Last Known Institution | Jiangnan University |
| OpenAlex ID | https://openalex.org/A5006458345 |
| ORCID iD | 0000-0001-7704-8633 |
| Works | 123 |

## Researcher papers

- [CAR-NK cells for cancer immunotherapy: from bench to bedside](https://scholariq.org/papers/car-nk-cells-for-cancer-immunotherapy-from-bench-to-bedside/)
- [Addictive Screen Use Trajectories and Suicidal Behaviors, Suicidal Ideation, and Mental Health in US Youths](https://scholariq.org/papers/addictive-screen-use-trajectories-and-suicidal-behaviors-suicidal-ideation-and/)
- [Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling](https://scholariq.org/papers/canagliflozin-primes-antitumor-immunity-by-triggering-pd-l1-degradation-in/)
- [High-efficient generation of natural killer cells from peripheral blood with preferable cell vitality and enhanced cytotoxicity by combination of IL-2, IL-15 and IL-18](https://scholariq.org/papers/high-efficient-generation-of-natural-killer-cells-from-peripheral-blood-with/)
- [A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer](https://scholariq.org/papers/a-current-review-of-dose-escalated-radiotherapy-in-locally-advanced-non-small/)
- [The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis](https://scholariq.org/papers/the-prognostic-value-of-ca19-9-response-after-neoadjuvant-therapy-in-patients/)
- [T lymphocyte cell: A pivotal player in lung cancer](https://scholariq.org/papers/t-lymphocyte-cell-a-pivotal-player-in-lung-cancer/)
- [Citric Acid Promotes Immune Function by Modulating the Intestinal Barrier](https://scholariq.org/papers/citric-acid-promotes-immune-function-by-modulating-the-intestinal-barrier/)
- [A MRI-based radiomics model predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma](https://scholariq.org/papers/a-mri-based-radiomics-model-predicting-radiation-induced-temporal-lobe-injury-in/)
- [Anlotinib Enhances the Antitumor Activity of High‐Dose Irradiation Combined with Anti‐PD‐L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer](https://scholariq.org/papers/anlotinib-enhances-the-antitumor-activity-of-high-dose-irradiation-combined-with/)
- [P59.13 The Prediction Performance of TP53 / RB1 Co-Mutation on Small-Cell Lung Cancer Transformation in Patients With Non-Small Cell Lung Cancer](https://scholariq.org/papers/p59-13-the-prediction-performance-of-tp53-rb1-co-mutation-on-small-cell-lung/)

## Researcher topics

- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

## Researcher university

- [Jiangnan University](https://scholariq.org/institutions/jiangnan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.